RECRUITING

Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

Description

This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future

Study Overview

Study Details

Study overview

This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future

Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

Condition
Cancer Screening
Intervention / Treatment

-

Contacts and Locations

Minnesota

University of Minnesota, Minnesota, Minnesota, United States, 55455

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years and older
  • * Able to provide voluntary written consent prior to the performance of any research related activity. Patients who can provide informed consent
  • * Able to understand, speak, read, and write in English
  • * Patients who have undergone hysterectomy, or plan to have a hysterectomy
  • * Patients who are transgender and gender diverse"
  • * Opted out of research
  • * \<18 years old
  • * Lacks capacity to consent/has diminished capacity to consent
  • * Cannot provide informed consent
  • * Those on the study's community advisory board

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Minnesota,

Meredith Wise, PRINCIPAL_INVESTIGATOR, University of Minnesota

Study Record Dates

2027-06-30